JPH0339063B2 - - Google Patents
Info
- Publication number
- JPH0339063B2 JPH0339063B2 JP57109192A JP10919282A JPH0339063B2 JP H0339063 B2 JPH0339063 B2 JP H0339063B2 JP 57109192 A JP57109192 A JP 57109192A JP 10919282 A JP10919282 A JP 10919282A JP H0339063 B2 JPH0339063 B2 JP H0339063B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- compound
- present
- observed
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 claims description 5
- VUNXBQRNMNVUMV-UHFFFAOYSA-N phenyl(piperazin-1-yl)methanone Chemical class C=1C=CC=CC=1C(=O)N1CCNCC1 VUNXBQRNMNVUMV-UHFFFAOYSA-N 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 7
- 108090000317 Chymotrypsin Proteins 0.000 description 6
- 229960002376 chymotrypsin Drugs 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- -1 4-substituted phenol Chemical class 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- VDLWTJCSPSUGOA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalene-1-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)CCCC2=C1 VDLWTJCSPSUGOA-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- TWADEBCIPVNACR-ZDUSSCGKSA-N (2s)-2-(n-(4-methylphenyl)sulfonylanilino)propanoic acid Chemical compound C=1C=C(C)C=CC=1S(=O)(=O)N([C@@H](C)C(O)=O)C1=CC=CC=C1 TWADEBCIPVNACR-ZDUSSCGKSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- SKAWDTAMLOJQNK-UHFFFAOYSA-N 2-acetamido-3-(4-hydroxyphenyl)propanoic acid ethyl ester Chemical compound CCOC(=O)C(NC(C)=O)CC1=CC=C(O)C=C1 SKAWDTAMLOJQNK-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 208000016222 Pancreatic disease Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BULLHNJGPPOUOX-UHFFFAOYSA-N chloroacetone Chemical compound CC(=O)CCl BULLHNJGPPOUOX-UHFFFAOYSA-N 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- BVNMUHYZMQDZPJ-UHFFFAOYSA-N methanesulfonic acid;[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl] 1,2,3,4-tetrahydronaphthalene-1-carboxylate Chemical compound CS(O)(=O)=O.C1CN(C(C)C)CCN1C(=O)C(C=C1)=CC=C1OC(=O)C1C2=CC=CC=C2CCC1 BVNMUHYZMQDZPJ-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 208000024691 pancreas disease Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57109192A JPS58225080A (ja) | 1982-06-25 | 1982-06-25 | ベンゾイルピペラジン誘導体 |
AU15931/83A AU545463B2 (en) | 1982-06-25 | 1983-06-20 | Benzoyl piperacine esters |
AT83303583T ATE28868T1 (de) | 1982-06-25 | 1983-06-22 | Benzoylpiperazinester und verfahren zu ihrer herstellung. |
EP83303583A EP0098713B1 (en) | 1982-06-25 | 1983-06-22 | Benzoylpiperazine esters and a process for their production |
DE8383303583T DE3372966D1 (en) | 1982-06-25 | 1983-06-22 | Benzoylpiperazine esters and a process for their production |
ES523561A ES523561A0 (es) | 1982-06-25 | 1983-06-23 | Proceso para producir un ester de benzoilpiperazina. |
CA000431034A CA1210005A (en) | 1982-06-25 | 1983-06-23 | Benzoylpiperazine esters and a process for their production |
DK290583A DK158983C (da) | 1982-06-25 | 1983-06-23 | Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf |
ZA834600A ZA834600B (en) | 1982-06-25 | 1983-06-23 | Benzoylpiperazine esters and a process for their production |
KR1019830002868A KR900003278B1 (ko) | 1982-06-25 | 1983-06-25 | 벤조일 피페라진 에스테르의 제조방법 |
US06/796,525 US4898876A (en) | 1982-06-25 | 1985-11-12 | Benzoylpiperazine esters and a process for their production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57109192A JPS58225080A (ja) | 1982-06-25 | 1982-06-25 | ベンゾイルピペラジン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58225080A JPS58225080A (ja) | 1983-12-27 |
JPH0339063B2 true JPH0339063B2 (no) | 1991-06-12 |
Family
ID=14503961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57109192A Granted JPS58225080A (ja) | 1982-06-25 | 1982-06-25 | ベンゾイルピペラジン誘導体 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS58225080A (no) |
ZA (1) | ZA834600B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59222484A (ja) * | 1983-06-02 | 1984-12-14 | Kowa Co | テトラヒドロナフチルカルボン酸フエニルエステル誘導体 |
JPS608225A (ja) * | 1983-06-29 | 1985-01-17 | Kowa Co | 腸管吸収医薬組成物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56158737A (en) * | 1980-05-07 | 1981-12-07 | Kowa Co | Phenyl ester |
-
1982
- 1982-06-25 JP JP57109192A patent/JPS58225080A/ja active Granted
-
1983
- 1983-06-23 ZA ZA834600A patent/ZA834600B/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56158737A (en) * | 1980-05-07 | 1981-12-07 | Kowa Co | Phenyl ester |
Also Published As
Publication number | Publication date |
---|---|
ZA834600B (en) | 1984-08-29 |
JPS58225080A (ja) | 1983-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4439438A (en) | Esters of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such esters | |
DE2500157A1 (de) | Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung | |
RU2049779C1 (ru) | Производные 4-аминофенола или их n-алкильные или солевые производные, проявляющие противовоспалительную активность | |
JPH06199887A (ja) | 新規なエリスロマイシン誘導体、それらの製造法及びそれらの薬剤としての用途 | |
US4882349A (en) | Pyrrolacetic amides having antiinflammatory activity | |
KR0167553B1 (ko) | 점액조절 및 항허혈 성질을 갖는 산화방지 약제로서 유용한 2,3-디히드로-5-옥시-4,6,7-트리메틸벤조푸란 2-(rs)-치환체 | |
JP2813375B2 (ja) | アセタゾールアミド関連化合物 | |
DK158983B (da) | Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf | |
JPS59222484A (ja) | テトラヒドロナフチルカルボン酸フエニルエステル誘導体 | |
HU199785B (en) | Process for producing pyrrolidine-2-(1,3-dicarbonyl) derivatives and pharmaceutical compositions comprising same as active ingredient | |
JPS63502658A (ja) | 新規な物質の組成 | |
JPH0339063B2 (no) | ||
US4521538A (en) | Ester of the 1-methyl-5-p-toluoylpyrrole-2-acetic acid having antiinflammatory, mucolytic and antitussive properties, process for its preparation and pharmaceutical compositions containing them | |
JP2640953B2 (ja) | 芳香族複素環化合物 | |
JP3310687B2 (ja) | キノン誘導体 | |
FR2491064A1 (fr) | Quinolones, leurs procedes de preparation et composition therapeutique les contenant | |
JP2765001B2 (ja) | プロテアーゼ阻害剤 | |
US7671197B2 (en) | Process for the purification of meloxicam | |
JP2862912B2 (ja) | 5’―(4―プロピルまたは4―イソプロピルピペラジニル)ベンゾキサジノリファマイシン誘導体 | |
US5270338A (en) | Acetazolamide-related compounds, process for their preparation, and pharmaceutical composition containing the same | |
JPS59199693A (ja) | インドリルグリシルセフアロスポリン誘導体 | |
CA1234572A (en) | Process for preparing pyridinecarboxylic esters of dopamine and of its n-alkyl derivatives | |
JPS60260540A (ja) | ジフタル酸エステル誘導体及びその製造法,並びにこれを有効成分とする抗潰瘍剤 | |
JPS6330462A (ja) | 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤 | |
JPH04257581A (ja) | ピペリジノメチルピリジン誘導体 |